SEC Contract Filing

Filing Date: 2020-08-10

Document Content:
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>tptx-ex102_175.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
tptx-ex102_175.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.2</p>
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-variant: small-caps;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;">TURNING POINT THERAPEUTICS, INC. </p>
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-variant: small-caps;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;">EXECUTIVE <font style="font-variant: normal;">EMPLOYMENT AGREEMENT</font></p>
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">for</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ANDREW PARTRIDGE</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Executive Employment Agreement (this &#8220;<font style="font-weight:bold;">Agreement</font>&#8221;), is made and entered into as of June 26, 2020, by and between Andrew Partridge (&#8220;<font style="font-weight:bold;">Executive</font>&#8221;) and Turning Point Therapeutics, Inc. (the &#8220;<font style="font-weight:bold;">Company</font>&#8221;).&nbsp;&nbsp;&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;color:#000000;font-variant: small-caps;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;"><a name="_DV_C161"></a>Whereas<font style="font-weight:normal;font-variant: normal;">, the Company desires for Executive to provide services to the Company, and wishes to provide Executive with certain compensation and benefits in return for such employment services; and</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;color:#000000;font-variant: small-caps;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;">Whereas<font style="font-weight:normal;font-variant: normal;">, Executive wishes to be employed by the Company and to provide personal services to the Company in return for certain compensation and benefits. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-variant: small-caps;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;">Now, Therefore<font style="font-weight:normal;font-variant: normal;">, in consideration of the mutual promises and covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1.<font style="margin-left:36pt;"></font>Employment by the Company.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1.1<font style="margin-left:36pt;"></font>Position.<font style="font-weight:normal;">&nbsp;&nbsp;Executive shall serve as the Company&#8217;s Executive Vice President &amp; Chief Commercial Officer, reporting to Athena Countouriotis, M.D., the Company&#8217;s President &amp; CEO (the &#8220;</font>CEO<font style="font-weight:normal;">&#8221;).&nbsp;&nbsp;Executive&#8217;s commencement of employment with the Company will be on or before July 13, 2020 (such actual date of commencement of employment with the Company, the &#8220;</font>Start Date<font style="font-weight:normal;">&#8221;). During the term of Executive&#8217;s employment with the Company, Executive will devote Executive&#8217;s best efforts and substantially all of Executive&#8217;s business time and attention to the business of the Company, except for approved vacation periods and reasonable periods of illness or other incapacities permitted by the Company&#8217;s general employment policies.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1.2<font style="margin-left:36pt;"></font>Duties and Location.<font style="font-weight:normal;">&nbsp;&nbsp;Executive shall perform such duties as are customarily associated with the position of Executive Vice President &amp; Chief Commercial Officer and such other duties as are assigned to Executive by the CEO.&nbsp;&nbsp;Executive&#8217;s primary office location shall be the Company&#8217;s headquarters located in San Diego, California.&nbsp;&nbsp;Subject to the terms of this Agreement, th